Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Diamond

Showing results (141-150 of 347) with videos related to

Pageof 35
Sort By:
Clinical Biochemistry|June 1, 1973
A comprehensive gas chromatographic drug screening procedure for the clinical laboratoryW C Griffiths, S K Oleksyk, I Diamond
Annals of Neurology|January 1, 1979
Inhibition of the evoked release of acetylcholine by the porphyrin precursor delta-aminolevulinic acidJ C Bornstein, J B Pickett, I Diamond
Advances in Neurology|January 1, 1982
A new animal model for Tourette syndromeB I Diamond, M G Reyes, R Borison
Proceedings of the National Academy of Sciences of the United States of America|January 19, 2000
Regulation of expanded polyglutamine protein aggregation and nuclear localization by the glucocorticoid receptorM I Diamond, M R Robinson, K R Yamamoto
ACS Chemical Biology|February 25, 2009
AR inhibitors identified by high-throughput microscopy detection of conformational change and subcellular localizationJeremy O Jones, W Frank An, Marc I Diamond
The Journal of Biological Chemistry|November 18, 2008
Conformational diversity of wild-type Tau fibrils specified by templated conformation changeBess Frost, Julian Ollesch, Holger Wille, et al.
Acta Neuropathologica|April 8, 2021
Tau strains shape diseaseJaime Vaquer-Alicea, Marc I Diamond, Lukasz A Joachimiak
Human Molecular Genetics|June 5, 2003
Polyglutamine protein aggregation and toxicity are linked to the cellular stress responseK J Cowan, M I Diamond, W J Welch
International Journal of Neurology|January 1, 1980
The role of substance P in the nigrostriatal systemR L Borison, H L Klawans, B I Diamond
Neuropharmacology|December 1, 1981
Site-specific blockade of dopamine receptors by neuroleptic agents in human brainR L Borison, J Z Fields, B I Diamond
Pageof 35

Showing results (141-150 of 347) with videos related to

Sort By:
Pageof 35
Clinical Biochemistry|June 1, 1973
A comprehensive gas chromatographic drug screening procedure for the clinical laboratoryW C Griffiths, S K Oleksyk, I Diamond
Annals of Neurology|January 1, 1979
Inhibition of the evoked release of acetylcholine by the porphyrin precursor delta-aminolevulinic acidJ C Bornstein, J B Pickett, I Diamond
Advances in Neurology|January 1, 1982
A new animal model for Tourette syndromeB I Diamond, M G Reyes, R Borison
Proceedings of the National Academy of Sciences of the United States of America|January 19, 2000
Regulation of expanded polyglutamine protein aggregation and nuclear localization by the glucocorticoid receptorM I Diamond, M R Robinson, K R Yamamoto
ACS Chemical Biology|February 25, 2009
AR inhibitors identified by high-throughput microscopy detection of conformational change and subcellular localizationJeremy O Jones, W Frank An, Marc I Diamond
The Journal of Biological Chemistry|November 18, 2008
Conformational diversity of wild-type Tau fibrils specified by templated conformation changeBess Frost, Julian Ollesch, Holger Wille, et al.
Acta Neuropathologica|April 8, 2021
Tau strains shape diseaseJaime Vaquer-Alicea, Marc I Diamond, Lukasz A Joachimiak
Human Molecular Genetics|June 5, 2003
Polyglutamine protein aggregation and toxicity are linked to the cellular stress responseK J Cowan, M I Diamond, W J Welch
International Journal of Neurology|January 1, 1980
The role of substance P in the nigrostriatal systemR L Borison, H L Klawans, B I Diamond
Neuropharmacology|December 1, 1981
Site-specific blockade of dopamine receptors by neuroleptic agents in human brainR L Borison, J Z Fields, B I Diamond
Pageof 35